
Bioorganic and Medicinal Chemistry Letters p. 475 - 480 (1999)
Update date:2022-08-04
Topics:
Britton, Thomas C.
Spinazze, Patrick G.
Hipskind, Philip A.
Zimmerman, Dennis M.
Zarrinmayeh, Hamideh
Schober, Douglas A.
Gehlert, Donald R.
Bruns, Robert F.
A series of benzo[b]thiophene-derived NPY-1 receptor antagonists is described. Systematic modification of the C-2 substituent afforded a 1000- fold range in Y1 receptor affinity. Appropriate substitution at the ortho and para positions of the C-2 phenyl ether produced a synergistic effect on Y1 binding affinity, which led to the discovery of the most active ligands, 12t (K(i) = 15 nM), 12u (K(i) = 11 nM), and 12v (K(i) = 13 nM).
View MoreContact:+86-519-86623222
Address:29F/D, 99 Yanling West Road, Changzhou, Jiangsu, China
Guangzhou Puho Pharmaceutical Technology Co. Ltd.
Contact:86-20-29848035/29848075
Address:No.166, Chaoyang East Road, Panyu District, Guangzhou City, Guangdong Province
Guangxi Bonger Pharmaceutical Co., Ltd
website:http://napo.lookchem.com/
Contact:+86-18817331185
Address:Donghai Industrial Zone, Tiandong Country,Guangxi,China
Weifang Adde Economic And Trade Co.,LTD.
Contact:86-536-8885548
Address:Room 1402,Wanda Plaza B Block,No.958,Yuanfei Road,Kuiwen District
Nanjing HuiBaiShi Biotechnology Co.,Ltd.
Contact:+86 (25)58745219
Address:No.606 Ningliu Road,LiuHe District.
Doi:10.1016/0040-4020(76)85179-4
(1976)Doi:10.1016/j.bioorg.2019.103480
(2020)Doi:10.1021/jacs.1c06906
(2021)Doi:10.1002/adsc.202000202
(2020)Doi:10.1021/ja982696q
(1998)Doi:10.1021/ja01238a035
(1944)